Implication of critical pharmacokinetic gene variants on therapeutic response to metformin in Type 2 diabetes
{{output}}
Aim: Metformin, an oral hypoglycemic drug is the first line of treatment for Type 2 diabetes individuals. We studied the effect of critical gene single nucleotide polymorphisms on the glucose lowering effect of metformin. ... ...
